These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 26133222)

  • 1. Assessment of early therapeutic response to sorafenib in renal cell carcinoma xenografts by dynamic contrast-enhanced and diffusion-weighted MR imaging.
    Jeon TY; Kim CK; Kim JH; Im GH; Park BK; Lee JH
    Br J Radiol; 2015 Sep; 88(1053):20150163. PubMed ID: 26133222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiparametric MR diffusion-weighted imaging for monitoring the ultra-early treatment effect of sorafenib in human hepatocellular carcinoma xenografts.
    Chen X; Ma Z; Huang Y; He L; Liang C; Shi C; Zhang Z; Liang C; Liu Z
    J Magn Reson Imaging; 2017 Jul; 46(1):248-256. PubMed ID: 27783444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamic contrast-enhanced magnetic resonance imaging pharmacodynamic biomarker study of sorafenib in metastatic renal carcinoma.
    Hahn OM; Yang C; Medved M; Karczmar G; Kistner E; Karrison T; Manchen E; Mitchell M; Ratain MJ; Stadler WM
    J Clin Oncol; 2008 Oct; 26(28):4572-8. PubMed ID: 18824708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined diffusion-weighted, blood oxygen level-dependent, and dynamic contrast-enhanced MRI for characterization and differentiation of renal cell carcinoma.
    Notohamiprodjo M; Staehler M; Steiner N; Schwab F; Sourbron SP; Michaely HJ; Helck AD; Reiser MF; Nikolaou K
    Acad Radiol; 2013 Jun; 20(6):685-93. PubMed ID: 23664397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of early response to concurrent chemoradiotherapy in cervical cancer: value of diffusion-weighted and dynamic contrast-enhanced MR imaging.
    Park JJ; Kim CK; Park SY; Simonetti AW; Kim E; Park BK; Huh SJ
    Magn Reson Imaging; 2014 Oct; 32(8):993-1000. PubMed ID: 24970025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monitoring anti-angiogenic therapy in colorectal cancer murine model using dynamic contrast-enhanced MRI: comparing pixel-by-pixel with region of interest analysis.
    Haney CR; Fan X; Markiewicz E; Mustafi D; Karczmar GS; Stadler WM
    Technol Cancer Res Treat; 2013 Feb; 12(1):71-8. PubMed ID: 22905809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diffusion weighted and dynamic contrast enhanced MRI as an imaging biomarker for stereotactic ablative body radiotherapy (SABR) of primary renal cell carcinoma.
    Reynolds HM; Parameswaran BK; Finnegan ME; Roettger D; Lau E; Kron T; Shaw M; Chander S; Siva S
    PLoS One; 2018; 13(8):e0202387. PubMed ID: 30114235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-molecular contrast agent dynamic contrast-enhanced (DCE)-MRI and diffusion-weighted (DW)-MRI in early assessment of bevacizumab treatment in breast cancer xenografts.
    Moestue SA; Huuse EM; Lindholm EM; Bofin A; Engebraaten O; Mælandsmo GM; Akslen LA; Gribbestad IS
    J Magn Reson Imaging; 2013 Nov; 38(5):1043-53. PubMed ID: 23908122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of diffusion-weighted imaging as an adjunct to contrast-enhanced breast MRI in evaluating residual breast cancer following neoadjuvant chemotherapy.
    Hahn SY; Ko EY; Han BK; Shin JH; Ko ES
    Eur J Radiol; 2014 Feb; 83(2):283-8. PubMed ID: 24315957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamic contrast-enhanced magnetic resonance imaging and diffusion-weighted imaging in the activity staging of terminal ileum Crohn's disease.
    Wu YC; Xiao ZB; Lin XH; Zheng XY; Cao DR; Zhang ZS
    World J Gastroenterol; 2020 Oct; 26(39):6057-6073. PubMed ID: 33132655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of diffusion-weighted, intravoxel incoherent motion, and dynamic contrast-enhanced MR imaging in the assessment of response to radiotherapy of lytic bone metastases from breast cancer.
    Gaeta M; Benedetto C; Minutoli F; D'Angelo T; Amato E; Mazziotti S; Racchiusa S; Mormina E; Blandino A; Pergolizzi S
    Acad Radiol; 2014 Oct; 21(10):1286-93. PubMed ID: 25088834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamic Contrast-Enhanced Magnetic Resonance Imaging as Imaging Biomarker for Vascular Normalization Effect of Infigratinib in High-FGFR-Expressing Hepatocellular Carcinoma Xenografts.
    Tran A; Koh TS; Prawira A; Ho RZW; Le TBU; Vu TC; Hartano S; Teo XQ; Chen WC; Lee P; Thng CH; Huynh H
    Mol Imaging Biol; 2021 Feb; 23(1):70-83. PubMed ID: 32909245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of tumor microvascular response to brivanib by dynamic contrast-enhanced 7-T MRI in an orthotopic xenograft model of hepatocellular carcinoma.
    Song KD; Choi D; Lee JH; Im GH; Yang J; Kim JH; Lee WJ
    AJR Am J Roentgenol; 2014 Jun; 202(6):W559-66. PubMed ID: 24848850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pilot study of DCE-MRI to predict progression-free survival with sorafenib therapy in renal cell carcinoma.
    Flaherty KT; Rosen MA; Heitjan DF; Gallagher ML; Schwartz B; Schnall MD; O'Dwyer PJ
    Cancer Biol Ther; 2008 Apr; 7(4):496-501. PubMed ID: 18219225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of the response of ocular adnexal lymphoma to chemotherapy using combined pretreatment dynamic contrast-enhanced and diffusion-weighted MRI.
    Guo P; Liu Z; Yan F; Wang J; Wei L; Lv H; Wang Z; Xian J
    Acta Radiol; 2016 Dec; 57(12):1490-1496. PubMed ID: 27012277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynamic contrast-enhanced and diffusion-weighted MRI of estrogen receptor-positive invasive breast cancers: Associations between quantitative MR parameters and Ki-67 proliferation status.
    Shin JK; Kim JY
    J Magn Reson Imaging; 2017 Jan; 45(1):94-102. PubMed ID: 27313102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imaging anti-angiogenic treatment response with DCE-VCT, DCE-MRI and DWI in an animal model of breast cancer bone metastasis.
    Bäuerle T; Bartling S; Berger M; Schmitt-Gräff A; Hilbig H; Kauczor HU; Delorme S; Kiessling F
    Eur J Radiol; 2010 Feb; 73(2):280-7. PubMed ID: 19070445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiparametric approach with diffusion-weighted imaging and dynamic contrast-enhanced MRI: a comparison study for differentiating between benign and malignant bone lesions in adults.
    Oh E; Yoon YC; Kim JH; Kim K
    Clin Radiol; 2017 Jul; 72(7):552-559. PubMed ID: 28325514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The application of dynamic contrast-enhanced MRI and diffusion-weighted MRI in patients with maxillofacial tumors.
    Kitamoto E; Chikui T; Kawano S; Ohga M; Kobayashi K; Matsuo Y; Yoshiura T; Obara M; Honda H; Yoshiura K
    Acad Radiol; 2015 Feb; 22(2):210-6. PubMed ID: 25442795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of quantitative magnetic resonance imaging parameters in the evaluation of treatment response in malignant tumors.
    Xu QG; Xian JF
    Chin Med J (Engl); 2015 Apr; 128(8):1128-33. PubMed ID: 25881611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.